Streetbeat News

Products Services

ASTI

Ascent Solar Technologies has announced that its initial concept paper for DE-FOA-0003057: 'Bipartisan Infrastructure Law: Silicon Solar Manufacturing, and Dual-use Photovoltaics Incubator' has received an 'Encouraged' decision from the Department of Energy (DOE).

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 8:32 pm

AGL

Agilon Health, Inc. (NYSE:AGL) announced that its Accountable Care Organizations (ACOs) achieved $107 million in gross savings and a 99.8% quality score during the 2022 performance year of the ACO REACH model. The eight REACH ACOs are responsible for the total cost and quality of approximately 90,000 Medicare Beneficiaries. The ACOs include 1,500 primary care physicians operating across 12 communities in Hawaii, New York, North Carolina, Ohio, Pennsylvania, and Texas.

Portfolio Pulse from Happy Mohamed

October 23, 2023 | 8:19 pm

CBAY

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) presented findings from its post-hoc analysis of the Phase 3 ENHANCE study of seladelpar for the treatment of primary biliary cholangitis (PBC). The study showed that treatment with seladelpar is correlated with a significant decrease in both IL-31 levels and levels of patient-reported itch. The company also presented a post-hoc analysis of four seladelpar clinical trials from 2015 to 2022, which found that PBC patients previously treated with ursodeoxycholic acid (UDCA) with elevated alkaline phosphatase (ALP) who did not meet current clinical guidelines for second-line treatment, nevertheless had a significant risk of disease progression.

Portfolio Pulse from Happy Mohamed

October 23, 2023 | 8:11 pm

SONY

Sony Group Corp.'s (NYSE:SONY) physical release of 'Marvel's Spider-Man 2' is reportedly causing installation issues for many players. The game's installation process halts at the 36% mark when the disc is inserted into the PS5 console. Despite various troubleshooting attempts, the issue persists.

Portfolio Pulse from Franca Quarneti

October 23, 2023 | 8:10 pm

MREO

RARE

Mereo BioPharma Group plc (NASDAQ:MREO) provided an update on recent program developments and third quarter 2023 financial information. The company reported cash and short-term deposits of $62.4M as of September 30, 2023. The company also announced interim data from the Phase 2 portion of the Phase 2/3 Orbit study, in collaboration with Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), showing a 67% reduction in annualized fracture rate in patients with osteogenesis imperfecta. The company is also reporting on the ATALANTa study, a multi-center, double-blind, placebo-controlled, proof-of-concept investigator-led study run in collaboration with University of Alabama at Birmingham (UAB).

Portfolio Pulse from Happy Mohamed

October 23, 2023 | 8:04 pm

GOOGL

MCO

Moody's Corporation and Google Cloud have announced a strategic partnership to develop generative AI applications for financial services professionals. The partnership aims to leverage Google Cloud's gen AI technologies and Moody's financial analysis expertise to create large language models (LLMs) that can quickly summarize financial data. Moody's will also provide access to its proprietary datasets through Google Cloud's BigQuery, and introduce Vertex AI Search to automate workflows and combine multiple data sets.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 7:34 pm

EXEL

Exelixis, Inc. (NASDAQ:EXEL) shares dropped after the company announced detailed results from its Phase 3 CABINET pivotal trial evaluating Cabozantinib in advanced neuroendocrine tumors. The results showed that Cabozantinib lowered the risk of disease progression or death in patients with pancreatic NET and in patients with extra-pancreatic NET, compared to the placebo. The company is also set to report third-quarter financial results on Nov. 1, with earnings estimated at 15 cents per share and revenue anticipated to be $472.20 million.

Portfolio Pulse from Ryan Gustafson

October 23, 2023 | 7:22 pm

INTC

NVDA

NVIDIA is reportedly working on Arm-based chips, which could pose a challenge to Intel. This news has led to an increase in Arm shares.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 7:18 pm

AAPL

AMC

AMZN

DIS

NFLX

Taylor Swift's concert film, 'The Eras Tour', has been a box office success, grossing $160.5 million worldwide. The film is part of an exclusive deal with AMC Entertainment Holdings Inc (NYSE:AMC), playing exclusively in theaters for 13 weeks. The film's success could benefit AMC, which is set to report Q3 results soon. Streaming rights for the film are also of interest, with potential contenders including Apple Inc (NASDAQ:AAPL), Walt Disney Co. (NYSE:DIS), Netflix Inc (NASDAQ:NFLX), and Amazon.com, Inc. (NASDAQ:AMZN).

Portfolio Pulse from Chris Katje

October 23, 2023 | 7:17 pm

SCBFF

USDCUSD

Standard Chartered Bank's SC Ventures and Deutsche Bank have successfully conducted a Universal Digital Payments Network (UDPN) proof-of-concept, facilitating real-time transactions between USD Coin and EURS stablecoins. The UDPN is a distributed ledger technology system that ensures smooth interactions between regulated stablecoins, CBDCs, and business IT systems. The aim of the UDPN Alliance is to transition from traditional payment infrastructures to streamlined, cost-effective digital payment solutions.

Portfolio Pulse from Murtuza Merchant

October 23, 2023 | 7:17 pm